China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
1.650
+0.010 (0.61%)
Oct 7, 2025, 4:00 PM EDT - Market closed
China SXT Pharmaceuticals Market Cap
China SXT Pharmaceuticals has a market cap or net worth of $190.29 million as of October 7, 2025. Its market cap has increased by 8,308.80% in one year.
Market Cap
190.29M
Enterprise Value
167.45M
1-Year Change
8,308.80%
Ranking
Category
Stock Price
$1.65
Market Cap Chart
Since January 4, 2019, China SXT Pharmaceuticals's market cap has increased from $129.31M to $190.29M, an increase of 47.15%. That is a compound annual growth rate of 5.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 190.29M | 10,673.72% |
| Dec 31, 2024 | 1.77M | -21.33% |
| Dec 29, 2023 | 2.25M | 54.15% |
| Dec 30, 2022 | 1.46M | -85.57% |
| Dec 31, 2021 | 10.10M | -48.92% |
| Dec 31, 2020 | 19.76M | -10.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.21B |
| Johnson & Johnson | 452.67B |
| AbbVie | 403.09B |
| UnitedHealth Group | 325.50B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.19B |